Breast Cancer Patients Receiving Tamoxifen Therapy at Two Private Hospitals in Central Java: Sociodemographic, Clinical, and Medication Profiles
Article Sidebar
Main Article Content
Page: 2291-2299
Abstract
Breast cancer is one of the most common types of cancer, including in Central Java Province, Indonesia, which reports a high incidence. The number of cases continues to increase, likely due to low public awareness of breast self-examination (BSE), limited health education, and a lack of motivation to undergo regular check-ups. One of the main treatment options is hormonal therapy, with Tamoxifen being the most widely used drug. To date, there is limited data on the sociodemographic and clinical characteristics among breast cancer patients who use Tamoxifen in Central Java. This information is essential for improving patient care and treatment strategies. This study aimed to describe the sociodemographic and clinical characteristics of breast cancer patients who received Tamoxifen at two private hospitals in Central Java. The results showed that most patients were under 50 years old (66%), had a low level of education (65.2%), and were employed (34.8%). Clinically, most patients were in advanced stages (56.5%), had no comorbidities (89.7%), and were not taking other medications (85%). These findings provide an initial overview of the profile of breast cancer patients using tamoxifen at two private hospitals in Central Java. However, these results cannot be generalized to the entire Central Java region due to the limitations of the study locations. Further studies with a broader scope are needed to obtain more representative data.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Osborne, A.; Adnani, Q.E.S.; Ahinkorah, B.O. Breast Cancer Incidence in Indonesia: A Sex-Disaggregated Analysis Using WHO Health Equity Assessment Toolkit Data. BMC Cancer 2025, 25, doi:10.1186/s12885-025-14332-4. DOI: https://doi.org/10.1186/s12885-025-14332-4
Jawa Tengah pemprov Tren Morbiditas Kanker Payudara Di Jawa Tengah Available online: https://jatengprov.go.id/.
Qari, A.S.; Mowais, A.H.; Alharbi, S.M.; Almuayrifi, M.J.; Al Asiri, A.A.; Alwatid, S.A.; Aljohani, A.A.; Alanazi, R.M.; Al Thoubaity, F. Adjuvant and Neoadjuvant Therapy for Breast Cancer: A Systematic Review. Eur. J. Breast Heal. 2024, 20, 156–166, doi:10.4274/ejbh.galenos.2024.2023-12-16.a[1] Osborne A, Adnani QES, Ahinkorah BO. Breast cancer incidence in Indonesia: a sex-disaggregated analysis using WHO health equity assessment toolkit data. BMC Cancer 2025;25. https://doi.org/10.1186/s12885-025-14332-4.
jawa tengah pemprov. Tren Morbiditas Kanker Payudara di Jawa Tengah 2023. https://jatengprov.go.id/.
Qari AS, Mowais AH, Alharbi SM, Almuayrifi MJ, Al Asiri AA, Alwatid SA, et al. Adjuvant and Neoadjuvant Therapy for Breast Cancer: A Systematic Review. European Journal of Breast Health 2024;20:156–66. https://doi.org/10.4274/ejbh.galenos.2024.2023-12-16. DOI: https://doi.org/10.4274/ejbh.galenos.2024.2023-12-16
Sassé B, Shaya S, Nimmo J, Cao K, Day D, Evans K, et al. Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study. Breast 2025;79. https://doi.org/10.1016/j.breast.2024.103861.
Yoo TK, Jang MJ, Lee E, Moon HG, Noh DY, Han W. Endocrine treatment-related symptoms and patient outcomes in breast cancer: A meta-analysis. Journal of Breast Cancer 2018;21:37–44. https://doi.org/10.4048/jbc.2018.21.1.37.
Mesa-Eguiagaray I, Wild SH, Rosenberg PS, Bird SM, Brewster DH, Hall PS, et al. Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data. British Journal of Cancer 2020;123:852–9. https://doi.org/10.1038/s41416-020-0938-z.
Ganz PA, Petersen L, Bower JE, Crespi CM. Impact of adjuvant endocrine therapy on quality of life and symptoms: Observational data over 12 months from the mind-body study. Journal of Clinical Oncology 2016;34:816–24. https://doi.org/10.1200/JCO.2015.64.3866.
Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast cancer, version 4.2021 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network 2021;19:484–94. https://doi.org/10.6004/jnccn.2021.0023.
Nelson HD, Cantor A, Humphrey L, Fu R, Pappas M, Daeges M, et al. Evidence Synthesis Number 124 Screening for Breast Cancer: A Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation. Evidence Syntheses 2016;124. DOI: https://doi.org/10.7326/M15-0969
Staynova R, Gavazova E, Kafalova D. Clinical Pharmacist-Led Interventions for Improving Breast Cancer Management—A Scoping Review. Current Oncology 2024;31:4178–91. https://doi.org/10.3390/curroncol31080312.
Wijaya JDA, Peter JSLA, Smaradhania N, Nelwan BJ, Purnama IP, Suwaryo PAW. Community-Based Sociodemographic Determinants of Chemotherapy Response in Breast Cancer: A Retrospective Study from Central Java, Indonesia. Media Publikasi Promosi Kesehatan Indonesia 2025;8:651–62. https://doi.org/10.56338/mppki.v8i8.7498.
Susilowati M, Afiyanti Y. The socio-demographic factors correlated with financial toxicity among patients with breast cancer in Indonesia. Journal of Public Health Research 2021;10:105–10. https://doi.org/10.4081/jphr.2021.2403.
Ningrum MP, Rahayu SRRR. Determinant Factors Related To Breast Cancer Incidence Among Women Of Reproductive Age (15-49 Years) in Indonesia (Advanced analysis of noncommunicable disesase research in 2016 data). Indonesian Journal of Public Health and Nutrition 2021.
Novelyn S, Simanjuntak TSB. Incidence, Histopathological Grade, and Type of Breast Cancer at Tarakan General Hospital, Jakarta, Indonesia in 2021. Asian Journal of Research in Infectious Diseases 2025;16:1–8. https://doi.org/10.9734/ajrid/2025/v16i5441.
Nindrea RD, Aryandono T, Lazuardi L, Dwiprahasto I. Review Article Association of Overweight and Obesity with Breast Cancer During Premenopausal Period in Asia: A Meta Analysis. International Journal of Preventive Medicine 2017;8:1–7. https://doi.org/10.4103/ijpvm.IJPVM.
Listyawardhani Y, Mudigdo A, Adriani RB. Risk Factors of Breast Cancer in Women: A New Evidence from Surakarta, Central Java, Indonesia 2018;3:76. https://doi.org/10.26911/mid.icph.2018.01.13.
Suharsimi Arikunto. Dasar-Dasar Evaluasi Pendidikan. Jakarta: Bumi Aksara; 2013.
Sihombing RJ. Perilaku Keluarga dan Peran Perawat dengan Tindakan Keluarga Dalam Melakukan Mobilisasi Pasien Stroke. Jik Jurnal Ilmu Kesehatan 2023;7:138. https://doi.org/10.33757/jik.v7i1.675.
Soh JY, Yahya MM, Bachok N, Wan Zain WZ, Wong MPK, Zakaria Z, et al. Factors associated with delay in seeking care for breast symptoms. BMC Women’s Health 2022;22:1–11. https://doi.org/10.1186/s12905-022-01898-5.
Mathew A, George PS, Kunnambath R, Mathew BS, Kumar A, Syampramod R, et al. Educational Status, Cancer Stage, and Survival in South India: A Population-Based Study. JCO Global Oncology 2020:1704–11. https://doi.org/10.1200/go.20.00259.
Manouchehri E, Taghipour A, Ghavami V, Ebadi A, Homaei F, Latifnejad Roudsari R. Night-shift work duration and breast cancer risk: an updated systematic review and meta-analysis. BMC Women’s Health 2021;21:1–16. https://doi.org/10.1186/s12905-021-01233-4.
Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T. Period3 structural variation: A circadian biomarker associated with breast cancer in young women. Cancer Epidemiology Biomarkers and Prevention 2005;14:268–70. https://doi.org/10.1158/1055-9965.268.14.1.
Jerome-D’Emilia B, Suplee PD, Robles-Rodriguez E, D’Emilia W. The impact of delays in low-income women’s breast cancer experiences. Cancer Nursing 2021;44:E43–52. https://doi.org/10.1097/NCC.0000000000000878.
Setyawan IB, Kurnia D, Setiaji K, Anwar SL, Purwanto DJ, Azhar Y, et al. Sociodemographic disparities associated with advanced stages and distant metastatic breast cancers at diagnosis in Indonesia: a cross-sectional study. Annals of Medicine & Surgery 2023;85:4211–7. https://doi.org/10.1097/ms9.0000000000001030.
Dharmawan MS, Setyawan GB, Aryana IGNW. Karakteristik Kanker Payudara Pada Geriatri Di Rsud Sanglah Tahun 2015-2017. Jurnal Medika Udayana 2020. https://doi.org/10.24843.MU.2020.V9.i7.P10.
Alfalah R. Jenis Histopatologi Berdasarkan Stadium Pada Pasien Kanker Payudara di RSUCM Aceh Utara Tahun 2020. Matriks Jurnal Sosial Dan Sains 2022;4:21–30. https://doi.org/10.59784/matriks.v4i1.130.
Koczwara B, Meng R, Battersby M, Mangoni AA, Spence D, Lawn S. Comorbidities and their management in women with breast cancer—an Australian survey of breast cancer survivors. Supportive Care in Cancer 2023;31:1–8. https://doi.org/10.1007/s00520-023-07678-7.
Yeo W, Mo FKF, Pang E, Suen JJS, Koh J, Loong HHF, et al. Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy. BMC Women’s Health 2017;17:1–11. https://doi.org/10.1186/s12905-017-0409-8.
Nechuta S, Bette Bette J. Caan, Chen WY, Kwan ML, Wei Lu6 HC, Poole EM, et al. post-diagnosis cruciferous vegetable consumption and breast cancer outcomes : a report from the after breast cancer pooling project. Bone 2012;23:1–7. https://doi.org/10.1158/1055-9965.EPI-13-0446.Post-diagnosis.
Fillon M. Breast cancer survivors face greater cardiometabolic risks. CA: A Cancer Journal for Clinicians 2022;72:303–4. https://doi.org/10.3322/caac.21746.
Heery, APRN, AOCNS, CBCN M. Precautions for Patients Taking Tamoxifen or Aromatase Inhibitors. Journal of the Advanced Practitioner in Oncology 2023;14:478–82. https://doi.org/10.6004/jadpro.2023.14.6.2.
Sassé, B.; Shaya, S.; Nimmo, J.; Cao, K.; Day, D.; Evans, K.; Healy, C.; Ho, G.Y.; Kruss, G.; McCartney, A.; et al. Evaluating the Impact of a Tertiary Multidisciplinary Meeting in Metastatic Breast Cancer: A Prospective Study. Breast 2025, 79, doi:10.1016/j.breast.2024.103861. DOI: https://doi.org/10.1016/j.breast.2024.103861
Yoo, T.K.; Jang, M.J.; Lee, E.; Moon, H.G.; Noh, D.Y.; Han, W. Endocrine Treatment-Related Symptoms and Patient Outcomes in Breast Cancer: A Meta-Analysis. J. Breast Cancer 2018, 21, 37–44, doi:10.4048/jbc.2018.21.1.37. DOI: https://doi.org/10.4048/jbc.2018.21.1.37
Mesa-Eguiagaray, I.; Wild, S.H.; Rosenberg, P.S.; Bird, S.M.; Brewster, D.H.; Hall, P.S.; Cameron, D.A.; Morrison, D.; Figueroa, J.D. Distinct Temporal Trends in Breast Cancer Incidence from 1997 to 2016 by Molecular Subtypes: A Population-Based Study of Scottish Cancer Registry Data. Br. J. Cancer 2020, 123, 852–859, doi:10.1038/s41416-020-0938-z. DOI: https://doi.org/10.1038/s41416-020-0938-z
Ganz, P.A.; Petersen, L.; Bower, J.E.; Crespi, C.M. Impact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data over 12 Months from the Mind-Body Study. J. Clin. Oncol. 2016, 34, 816–824, doi:10.1200/JCO.2015.64.3866. DOI: https://doi.org/10.1200/JCO.2015.64.3866
Gradishar, W.J.; Moran, M.S.; Abraham, J.; Aft, R.; Agnese, D.; Allison, K.H.; Blair, S.L.; Burstein, H.J.; Dang, C.; Elias, A.D.; et al. Breast Cancer, Version 4.2021 Featured Updates to the NCCN Guidelines. JNCCN J. Natl. Compr. Cancer Netw. 2021, 19, 484–494, doi:10.6004/jnccn.2021.0023. DOI: https://doi.org/10.6004/jnccn.2021.0023
Nelson, H.D.; Cantor, A.; Humphrey, L.; Fu, R.; Pappas, M.; Daeges, M.; Griffin, J. Evidence Synthesis Number 124 Screening for Breast Cancer: A Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation. Evid. Synth. 2016, 124. DOI: https://doi.org/10.7326/M15-0970
Staynova, R.; Gavazova, E.; Kafalova, D. Clinical Pharmacist-Led Interventions for Improving Breast Cancer Management—A Scoping Review. Curr. Oncol. 2024, 31, 4178–4191, doi:10.3390/curroncol31080312. DOI: https://doi.org/10.3390/curroncol31080312
Wijaya, J.D.A.; Peter, J.S.L.A.; Smaradhania, N.; Nelwan, B.J.; Purnama, I.P.; Suwaryo, P.A.W. Community-Based Sociodemographic Determinants of Chemotherapy Response in Breast Cancer: A Retrospective Study from Central Java, Indonesia. Media Publ. Promosi Kesehat. Indones. 2025, 8, 651–662, doi:10.56338/mppki.v8i8.7498. DOI: https://doi.org/10.56338/mppki.v8i8.7498
Susilowati, M.; Afiyanti, Y. The Socio-Demographic Factors Correlated with Financial Toxicity among Patients with Breast Cancer in Indonesia. J. Public health Res. 2021, 10, 105–110, doi:10.4081/jphr.2021.2403. DOI: https://doi.org/10.4081/jphr.2021.2403
Ningrum, M.P.; Rahayu, S.R.R. Determinant Factors Related To Breast Cancer Incidence Among Women Of Reproductive Age (15-49 Years) In Indonesia (Advanced Analysis of Noncommunicable Disesase Research in 2016 Data). Indones. J. Public Heal. Nutr. 2021.
Novelyn, S.; Simanjuntak, T.S.B. Incidence, Histopathological Grade, and Type of Breast Cancer at Tarakan General Hospital, Jakarta, Indonesia in 2021. Asian J. Res. Infect. Dis. 2025, 16, 1–8, doi:10.9734/ajrid/2025/v16i5441. DOI: https://doi.org/10.9734/ajrid/2025/v16i5441
Nindrea, R.D.; Aryandono, T.; Lazuardi, L.; Dwiprahasto, I. Review Article Association of Overweight and Obesity with Breast Cancer During Premenopausal Period in Asia: A Meta‑Analysis. Int. J. Prev. Med. 2017, 8, 1–7, doi:10.4103/ijpvm.IJPVM.
Listyawardhani, Y.; Mudigdo, A.; Adriani, R.B. Risk Factors of Breast Cancer in Women: A New Evidence from Surakarta, Central Java, Indonesia. 2018, 3, 76, doi:10.26911/mid.icph.2018.01.13. DOI: https://doi.org/10.26911/mid.icph.2018.01.13
Suharsimi Arikunto Dasar-Dasar Evaluasi Pendidikan; Bumi Aksara: Jakarta, 2013;
Sihombing, R.J. Perilaku Keluarga Dan Peran Perawat Dengan Tindakan Keluarga Dalam Melakukan Mobilisasi Pasien Stroke. Jik J. Ilmu Kesehat. 2023, 7, 138, doi:10.33757/jik.v7i1.675. DOI: https://doi.org/10.33757/jik.v7i1.675
Soh, J.Y.; Yahya, M.M.; Bachok, N.; Wan Zain, W.Z.; Wong, M.P.K.; Zakaria, Z.; Hashim Isa Merican, S.R.; Md Hashim, M.N.; Wan Mokhter, W.M.; Ramely, R.; et al. Factors Associated with Delay in Seeking Care for Breast Symptoms. BMC Womens. Health 2022, 22, 1–11, doi:10.1186/s12905-022-01898-5. DOI: https://doi.org/10.1186/s12905-022-01898-5
Mathew, A.; George, P.S.; Kunnambath, R.; Mathew, B.S.; Kumar, A.; Syampramod, R.; Booth, C.M. Educational Status, Cancer Stage, and Survival in South India: A Population-Based Study. JCO Glob. Oncol. 2020, 1704–1711, doi:10.1200/go.20.00259. DOI: https://doi.org/10.1200/GO.20.00259
Manouchehri, E.; Taghipour, A.; Ghavami, V.; Ebadi, A.; Homaei, F.; Latifnejad Roudsari, R. Night-Shift Work Duration and Breast Cancer Risk: An Updated Systematic Review and Meta-Analysis. BMC Womens. Health 2021, 21, 1–16, doi:10.1186/s12905-021-01233-4. DOI: https://doi.org/10.1186/s12905-021-01233-4
Zhu, Y.; Brown, H.N.; Zhang, Y.; Stevens, R.G.; Zheng, T. Period3 Structural Variation: A Circadian Biomarker Associated with Breast Cancer in Young Women. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 268–270, doi:10.1158/1055-9965.268.14.1. DOI: https://doi.org/10.1158/1055-9965.268.14.1
Jerome-D’Emilia, B.; Suplee, P.D.; Robles-Rodriguez, E.; D’Emilia, W. The Impact of Delays in Low-Income Women’s Breast Cancer Experiences. Cancer Nurs. 2021, 44, E43–E52, doi:10.1097/NCC.0000000000000878. DOI: https://doi.org/10.1097/NCC.0000000000000878
Setyawan, I.B.; Kurnia, D.; Setiaji, K.; Anwar, S.L.; Purwanto, D.J.; Azhar, Y.; Budijitno, S.; Suprabawati, D.G.A.; Priyono, S.H.; Siregar, B.A.; et al. Sociodemographic Disparities Associated with Advanced Stages and Distant Metastatic Breast Cancers at Diagnosis in Indonesia: A Cross-Sectional Study. Ann. Med. Surg. 2023, 85, 4211–4217, doi:10.1097/ms9.0000000000001030. DOI: https://doi.org/10.1097/MS9.0000000000001030
Dharmawan, M.S.; Setyawan, G.B.; Aryana, I.G.N.W. Karakteristik Kanker Payudara Pada Geriatri Di Rsud Sanglah Tahun 2015-2017. J. Med. Udayana 2020, doi:10.24843.MU.2020.V9.i7.P10.
Alfalah, R. Jenis Histopatologi Berdasarkan Stadium Pada Pasien Kanker Payudara Di RSUCM Aceh Utara Tahun 2020. Matriks J. Sos. dan Sains 2022, 4, 21–30, doi:10.59784/matriks.v4i1.130. DOI: https://doi.org/10.59784/matriks.v4i1.130
Koczwara, B.; Meng, R.; Battersby, M.; Mangoni, A.A.; Spence, D.; Lawn, S. Comorbidities and Their Management in Women with Breast Cancer—an Australian Survey of Breast Cancer Survivors. Support. Care Cancer 2023, 31, 1–8, doi:10.1007/s00520-023-07678-7. DOI: https://doi.org/10.1007/s00520-023-07678-7
Yeo, W.; Mo, F.K.F.; Pang, E.; Suen, J.J.S.; Koh, J.; Loong, H.H.F.; Yip, C.C.H.; Ng, R.Y.W.; Yip, C.H.W.; Tang, N.L.S.; et al. Profiles of Lipids, Blood Pressure and Weight Changes among Premenopausal Chinese Breast Cancer Patients after Adjuvant Chemotherapy. BMC Womens. Health 2017, 17, 1–11, doi:10.1186/s12905-017-0409-8. DOI: https://doi.org/10.1186/s12905-017-0409-8
Nechuta, S.; Bette Bette J. Caan; Chen, W.Y.; Kwan, M.L.; Wei Lu6, H.C.; Poole, E.M.; Flatt, S.W.; Zheng, W.; An, J.P.P.; Shu, X.O. Post-Diagnosis Cruciferous Vegetable Consumption and Breast Cancer Outcomes : A Report from the after Breast Cancer Pooling Project. Bone 2012, 23, 1–7, doi:10.1158/1055-9965.EPI-13-0446.Post-diagnosis.
Fillon, M. Breast Cancer Survivors Face Greater Cardiometabolic Risks. CA. Cancer J. Clin. 2022, 72, 303–304, doi:10.3322/caac.21746. DOI: https://doi.org/10.3322/caac.21746
Heery, M.; Corbett, P.; Zelkowitz R. Precautions for Patients Taking Tamoxifen or Aromatase Inhibitors. J. Adv. Pract. Oncol. 2023, 14, 478–482, doi:10.6004/jadpro.2023.14.6.2. DOI: https://doi.org/10.6004/jadpro.2023.14.6.2